• Serves as the senior regional clinical strategist for GE HealthCare's Amyloid PET portfolio, including Vizamyl and amyloid quantification solutions. • Drives clinical care pathway differentiation with radiology and imaging center decision makers. • Responsible for shaping and driving large-scale clinical differentiation strategy aligned with GE HealthCare commercial objectives. • Leads strategic KOL partnerships and influences regional commercial planning across multiple product lines. • Requires specialized and comprehensive knowledge across PET radiopharmaceutical diagnostics, quantification methodologies, reimbursement considerations, and evolving diagnostic care pathways. • Defines engagement frameworks that strengthen competitive positioning and long-term portfolio growth. • Influences development of regional strategy and contributes to broader commercial planning discussions. • Integrates insights from Sales, Marketing, Product Marketing, and external clinical stakeholders to optimize portfolio positioning. • Uses high level of judgment to address complex clinical, operational, and commercial challenges. • Constructs strategic recommendations that impact territory planning and resource allocation. • Uses multiple internal and selected external sources to guide decisions. • May lead high-visibility regional or cross-functional initiatives. • Communicates difficult or sensitive information at executive levels. • Mentors senior team members and elevates overall clinical capability across the region.